Signs |
No. of Cases(n=97) |
Percentage |
Papilloedema |
7 |
7.20% |
Cranial nerve palsy |
14 |
14.40% |
Optic atrophy |
3 |
3.10% |
Ataxia |
12 |
12.40% |
Focal neurological deficit |
7 |
7.20% |
Associated with other systemic diseases |
5 |
5.20% |
Recurrences |
2 |
2.10% |
Group of Tumor |
No. of Cases (n=97) |
Percentage |
Neuronal and mixed glioneuronal tumors |
31 |
31.90% |
Meningeal tumors |
15 |
15.50% |
SEGA |
12 |
12.30% |
Ependymal tumors |
6 |
6.20% |
Other Astrocytic neoplasms |
15 |
15.40% |
Choroid plexus tumors |
10 |
10.30% |
Embryonal tumors |
4 |
4.10% |
NHL |
2 |
2.10% |
Metastasis |
1 |
1.03% |
Germ cell tumors (Teratoma) |
1 |
1.03% |
Tumor |
No. of cases (n=6078) |
% |
Neuronal and mixed glioneuronal tumors: |
|
|
Central neurocytoma |
30 |
0.40% |
Ganglioneurocytoma |
1 |
0.01% |
Total |
31 |
0.50% |
Meningeal tumors:- |
|
|
Transitional meningioma |
8 |
0.13% |
Fibroblastic meningioma |
3 |
0.04% |
Meningothelial meningioma |
3 |
0.04% |
Atypical meningioma |
1 |
0.01% |
Total |
15 |
0.25% |
Subependymal giant cell astrocytoma (SEGA) |
12 |
0.20% |
Ependymal tumors: - |
||
Ependymoma |
3 |
0.04% |
Subependymoma |
3 |
0.04.% |
Total |
6 |
0.09% |
Other glial tumors:- |
||
Pilocytic astrocytoma |
2 |
0.03% |
Grade 2 astrocytoma |
4 |
0.06% |
Grade
3 astrocytoma |
3 |
0.04% |
Grade 4 astrocytoma |
6 |
0.09% |
Total |
15 |
0.25% |
Choroid plexus tumors: - |
||
Choroid plexus papilloma |
8 |
0.13% |
Choroid plexus carcinoma |
2 |
0.03% |
Total |
10 |
0.16% |
Embryonal tumors: - |
||
Premitive neuroectodermal tumor |
3 |
0.04% |
Medulloepithelioma |
1 |
0.01% |
Total |
4 |
0.06% |
Non Hodgkin’s lymphoma |
2 |
0.03% |
Metastases |
1 |
0.01% |
Germ cell tumors (Teratoma) |
1 |
0.01% |
Total |
97 |
1.60% |
WHO GRADE |
No. of cases(n=93)* |
Percentage |
Grade I |
40 |
43% |
Grade II |
38 |
40.90% |
Grade III |
5 |
5.40% |
Grade IV |
10 |
10.70% |